US-based molecular diagnostics company DiaCarta has developed a new test to detect the new emerging Covid-19 variant, Omicron. The new multiplex qPCR-based test named QuantiVirus SARS-CoV-2 Variant Detection is based on DiaCarta’s proprietary XNA technology. It is designed to identify the SARS-CoV-2 virus and then distinguish various mutating variants. The company has secured CE/IVD marking and will […]

November 30, 2021 — Immunexpress’ SeptiCyte Rapid fully automated diagnostic tool has been granted 510(k) clearance from the U.S. Food and Drug Administration (FDA). The test can aid in the diagnosis of sepsis in one hour for patients suspected of having the illness. SeptiCyte Rapid uses reverse transcription polymerase chain reaction to quantify directly from blood […]

With the Thanksgiving holiday upon us, BioSpace felt it was important to give thanks for some of the positive things that have happened this year. And there are many! The accomplishments, opportunities and possibilities the scientific community has brought to bear, providing a way out of the COVID-19 pandemic and hope for the future of […]